Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Esophageal Strictures-II: Clinical Features and Management
Barrett Esophagus-II: Clinical Manifestations and Management
Gastroesophageal Reflux Disease II: Clinical Features and Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 3, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
Taylor Hallcox1, Daniel Stein1,2
1Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Esophageal Crohn's disease (CD) lacks specific treatments. This study suggests risankizumab, an interleukin-23 inhibitor, may be a promising option for managing this condition.
Area of Science:
Background: